CSI Market
Sign In | Register

Ionis Pharmaceuticals Inc (IONS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IONS Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Ionis Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent350.07
Short-term Investments, Total0.00
Cash & Short-term Investments350.00
Inventories50.83
Other Current Assets0.00
Total Current Assets2,491.27
Equipment/Property/Plant Net155.13
Long-term investments647.33
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent1,791.15
Total Assets2,994.50
Liabilities
Accounts Payable, Current AC47.70
Accrued Liabilities, Current115.78
Convertible Debt, Current LO0.00
Other Liabilities, Current149.28
Accrued Income Taxes, Current TA2.88
Total Current Liabilities315.64
Long-term debt0.00
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent2,239.13
Contract With Customer Liability Noncurrent75.75
Total Liabilities2,554.76
Stockholders' Equity
Common Stock Value0.17
Additional Paid In Capital Common Stock3,311.84
Retained Earnings / Accumulated Deficit-2,838.37
Accumulated Other Comprehensive Income-33.90
Other Equity-33.90
Common Stockholder's Equity439.74
Total Stockholder's Equity439.74
Liabilities & Stockholder's Equity2,994.50
4 historic quarters locked

Sign in to unlock the full Ionis Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Ionis Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 29, 2026
  • Source: form10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000874015-26-000251

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.